Summary by Futu AI
HighTide Therapeutics, Inc., announced on 11 March 2024 that pursuant to Section 2.07 of the Listing Rules of the Stock Exchange of Hong Kong Stock Exchange Limited, the Company has adopted the electronic publication of corporate communications, including Directors' Reports, Annual Accounts, Audit Reports, Interim Reports, Notices of Meetings, and Listing Documents, Circulars and Appointment Forms, etc. The Company informs non-registered shareholders that all future corporate communications will be made available via the Company's website and disclosable websites in place of printed copies. Shareholders should proactively check the relevant websites for the latest information and should provide an email address to the intermediary holding their shares. If a shareholder wishes to receive a printed copy, they must fill out a return form and submit an application to the Share Transfer Office within one year. THE COMPANY EMPHASIZES THAT IF SHAREHOLDERS STILL NEED PRINTED COPIES AFTER ONE YEAR, THEY WILL HAVE TO RESUBMIT THE APPLICATION.